| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/20/2008 | US7374756 Labeled monoclonal antibody binds Kaposi's sarcoma-associated herpesvirus (KSHV); use in diagnosis and prognosis |
| 05/20/2008 | CA2473759C Antibodies for detecting ecstasy-class analytes |
| 05/20/2008 | CA2469833C Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| 05/20/2008 | CA2419698C Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes |
| 05/20/2008 | CA2363947C Hiv peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv |
| 05/20/2008 | CA2229202C Methods for identifying antagonist or agonist to human opioid receptor-like 1 "orl1" |
| 05/20/2008 | CA2172630C Cellular and serum protein anchors and conjugates |
| 05/15/2008 | WO2008058251A1 Variants and methods of using transforming growth factor beta-9 |
| 05/15/2008 | WO2008058127A2 Agonist trkb antibodies and uses thereof |
| 05/15/2008 | WO2008057240A2 Crystalline anti-htnfalpha antibodies |
| 05/15/2008 | WO2008056833A1 ANTI-HUMAN Dlk-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO |
| 05/15/2008 | WO2008056705A1 M cell-specific antibody |
| 05/15/2008 | WO2008055916A2 New antigens for paratuberculosis diagnosis and vaccination |
| 05/15/2008 | WO2008055889A1 Compositions and methods of treating oncological, inflammatory and autoimmune diseases mediated by sema4a |
| 05/15/2008 | WO2008055795A1 Selection of human monoclonal antibodies by mammalian cell display |
| 05/15/2008 | WO2008055703A2 Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates |
| 05/15/2008 | WO2008055314A1 Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers |
| 05/15/2008 | WO2008028692A8 Method for screening drug candidates for inflammatory diseases mediated by lps-inducible cc chemokine receptor mechanism |
| 05/15/2008 | WO2008028192A3 Variable region sequences of il-31 monoclonal antibodies and methods of use |
| 05/15/2008 | WO2008014603A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/15/2008 | WO2007136893A3 Anti-fgf19 antibodies and methods using same |
| 05/15/2008 | WO2007127936A3 Methods and compositions for antibody therapy |
| 05/15/2008 | WO2007112054A3 Facilitation of translocation of molecules through the gastrointestinal tract |
| 05/15/2008 | WO2007089659A3 Tat-039 and methods of assessing and treating cancer |
| 05/15/2008 | US20080115244 Therapeutic antibodies comprising protective proteins for use in treatment and prevention of dental caries and streptococal infection; dentristry |
| 05/15/2008 | US20080114156 Monoclonal antibody secific to lymphocyte peripheral membrane protein for treating and preventing transplant rejection, blood, skin, autoimmune, allergic and diabetic disorders |
| 05/15/2008 | US20080113933 polynucleotide molecules that encode the Chlamydia polypeptides designated 60 kDa cysteine-rich membrane proteine which can be used to prevent, treat, and diagnose Chlamydia infection |
| 05/15/2008 | US20080113898 Methods for detecting and inhibiting angiogenesis using peptides |
| 05/15/2008 | US20080113449 G protein coupled receptor specific immunoglobulin for use in treatment and prevention of cell proliferative, cardiovascular and metabolic disorders |
| 05/15/2008 | US20080113424 Isolating dermatophagoides protein via anion exchange and hydrophobic gel adsorption |
| 05/15/2008 | US20080113388 Nematode ATP Synthase Subunit E-Like Sequences |
| 05/15/2008 | US20080113387 Immunoassay for Prion Disease |
| 05/15/2008 | US20080113385 Immunoglobulin for use in prevention and treatment inflammatory disease |
| 05/15/2008 | US20080112980 Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof |
| 05/15/2008 | US20080112964 Mutant Pneumolysin Proteins |
| 05/15/2008 | US20080112961 Using antibodies to mediate cytotoxicity and treat cell proliferative disorders; immunotherapy |
| 05/15/2008 | US20080112959 Smallpox monoclonal antibody |
| 05/15/2008 | US20080112958 Using epidermal growth factor receptor antagonist as therapeutic tool in treatment of cell proliferative disorders |
| 05/15/2008 | US20080112957 Composition comprising immunoglobulin specific to epidermal growth factor receptor for treatment of cell proliferative disorders |
| 05/15/2008 | US20080112956 Using membrane proteins concentration as cancer indicator |
| 05/15/2008 | US20080112951 Oligo/polysaccharides bound to carrier; immunogens; monoclonal antibodies; chimeric antibodies; kits; host cells; transgenic plants/animals |
| 05/15/2008 | US20080112948 Water-soluble globulin concentrate for improving growth in animals |
| 05/15/2008 | US20080112936 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 05/15/2008 | DE102006053385A1 Enterococcus faecalis- und/oder Enterococcus faecium-Antigen Enterococcus faecalis and / or Enterococcus faecium antigen |
| 05/15/2008 | CA2679859A1 Method for detecting and controlling cancer |
| 05/15/2008 | CA2669731A1 Anti-human dlk-1 antibody showing anti-tumor activity in vivo |
| 05/15/2008 | CA2669267A1 Methods of using transforming growth factor beata-9 |
| 05/15/2008 | CA2669205A1 Agonist trkb antibodies and uses thereof |
| 05/15/2008 | CA2669185A1 Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers |
| 05/15/2008 | CA2668131A1 Antagonists of pcsk9 |
| 05/15/2008 | CA2667894A1 Antagonists of pcsk9 |
| 05/15/2008 | CA2667869A1 Antagonists of pcsk9 |
| 05/15/2008 | CA2667655A1 Crystalline anti-htnfalpha antibodies |
| 05/15/2008 | CA2666308A1 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 05/15/2008 | CA2666306A1 4-1 bb ligand in inflammatory diseases |
| 05/14/2008 | EP1921144A2 Method for linking sequences of interest |
| 05/14/2008 | EP1921142A1 Selection of human monoclonal antibodies by eukaryotic cell display |
| 05/14/2008 | EP1921137A1 Antibody having inhibitory effect on amyloid fibril formation |
| 05/14/2008 | EP1921094A2 Method for presenting and removing substances |
| 05/14/2008 | EP1921090A1 Genetically modified antibody composition |
| 05/14/2008 | EP1921088A2 Peptides and related molecules that bind to tall-1 |
| 05/14/2008 | EP1920239A2 Detection and measurement of blood-feeding activity |
| 05/14/2008 | EP1920066A1 Cancerous disease modifying antibodies |
| 05/14/2008 | EP1920065A2 Anti-alpha v beta 6 antibodies and uses thereof |
| 05/14/2008 | EP1920061A1 GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES |
| 05/14/2008 | EP1919957A2 Cd33-specific single-chain immunotoxin and method of use |
| 05/14/2008 | EP1919955A1 Cancerous disease modifying antibodies |
| 05/14/2008 | EP1919954A2 Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins |
| 05/14/2008 | EP1919953A1 Antibodies directed against a ldl receptor |
| 05/14/2008 | EP1919952A2 Tcr-v-beta related peptides for treatment and diagnosis of autoimmune disease |
| 05/14/2008 | EP1919951A2 Anti-tnf-alpha antibodies and methods of use |
| 05/14/2008 | EP1919950A1 Optimized fc variants |
| 05/14/2008 | EP1919943A2 Melanoma-associated mhc class i associated oligopeptides and the uses thereof |
| 05/14/2008 | EP1919940A2 Antigenic peptides and their use |
| 05/14/2008 | EP1919504A2 Compositions and methods for production of immunoglobulins |
| 05/14/2008 | EP1919503A2 Identification and engineering of antibodies with variant fc regions and methods of using same |
| 05/14/2008 | EP1919491A2 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 05/14/2008 | EP1766025A4 Porcine sulfotransferase 2a1 polynucleotide sequence, protein, and methods of use for same |
| 05/14/2008 | EP1732880A4 Assays for amphetamine and methamphetamine |
| 05/14/2008 | EP1687026B1 Method for the treatment of multiple sclerosis by inhibiting il-17 activity |
| 05/14/2008 | EP1572087B1 Antibodies against cancer antigen tmeff2 and uses thereof |
| 05/14/2008 | EP1506009B1 Beta-glucan-based anti-fungal vaccines |
| 05/14/2008 | EP1461423B1 Antibody categorization based on binding characteristics |
| 05/14/2008 | EP1278540B1 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 05/14/2008 | EP1274728B1 Methods and compositions for the prevention and treatment of anemia |
| 05/14/2008 | EP1235934B1 Screening method for candidate drugs |
| 05/14/2008 | EP1087997B1 Monoclonal antibodies directed against the g3bp protein, and uses |
| 05/14/2008 | EP1035132B1 Monoclonal antibody inducing apoptosis |
| 05/14/2008 | EP1008650B1 Novel mapk kinase |
| 05/14/2008 | EP1003552B1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 05/14/2008 | EP0840749B1 The h-y antigen |
| 05/14/2008 | EP0833929B1 Chimeric antibodies for delivery of antigens to selected cells of the immune system |
| 05/14/2008 | EP0811075B1 A method for the isolation and purification of lipid cell-wall components |
| 05/14/2008 | EP0783313B1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 05/14/2008 | EP0763100B1 Method of purification of clostridium difficile toxin a and production of mono-specific antibodies |
| 05/14/2008 | EP0635132B2 Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
| 05/14/2008 | CN101180391A 因子XIIa形式 Form factor XIIa |
| 05/14/2008 | CN101180317A Method for the purification of antibodies |
| 05/14/2008 | CN101180316A High-level expression of recombinant antibody in a mammalian host cell |
| 05/14/2008 | CN101180315A Il-21 variants |